High Tech Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	70,183	77,513	76,772	102,947	73,287
Other Revenue	-	-	-0	-	-
Revenue	70,183	77,513	76,772	102,947	73,287
Revenue Growth (YoY)	-9.46%	0.97%	-25.43%	40.47%	-1.58%
Cost of Revenue	53,246	58,032	63,938	95,177	70,216
Gross Profit	16,937	19,481	12,834	7,770	3,071
Selling, General & Admin	3,122	3,790	2,601	2,705	3,310
Research & Development	816.56	-	-	-	-
Other Operating Expenses	62.15	59.44	61.83	47.33	115.54
Operating Expenses	4,081	3,923	2,745	2,843	3,483
Operating Income	12,856	15,558	10,089	4,927	-412.02
Interest Expense	-180.16	-787.27	-896.47	-463.69	-252.07
Interest & Investment Income	12.63	8	4.69	4.31	84.73
Currency Exchange Gain (Loss)	5.76	1,871	278.34	-829.89	-290.52
Other Non Operating Income (Expenses)	1,003	307.37	282.41	267.28	1.82
EBT Excluding Unusual Items	13,697	16,957	9,758	3,905	-868.07
Gain (Loss) on Sale of Investments	127.32	129.57	115.56	54.65	-
Gain (Loss) on Sale of Assets	3	-	-9.51	68.11	0.14
Pretax Income	13,828	17,087	9,864	4,028	-867.94
Income Tax Expense	2,353	3,377	1,787	-1,845	357.46
Net Income	11,475	13,710	8,076	5,873	-1,225
Net Income to Common	11,475	13,710	8,076	5,873	-1,225
Net Income Growth	-16.30%	69.75%	37.52%	-	-
Shares Outstanding (Basic)	-	11	7	11	11
Shares Outstanding (Diluted)	-	11	7	11	11
Shares Change (YoY)	-	49.99%	-33.33%	-	-
EPS (Basic)	-	1289.43	1139.33	552.32	-115.24
EPS (Diluted)	-	1289.43	1139.33	552.32	-115.24
EPS Growth	-	13.17%	106.28%	-	-
Free Cash Flow	15,102	12,558	-2,183	-4,359	6,068
Free Cash Flow Per Share	-	1181.10	-307.89	-409.94	570.68
Gross Margin	24.13%	25.13%	16.72%	7.55%	4.19%
Operating Margin	18.32%	20.07%	13.14%	4.79%	-0.56%
Profit Margin	16.35%	17.69%	10.52%	5.71%	-1.67%
Free Cash Flow Margin	21.52%	16.20%	-2.84%	-4.23%	8.28%
EBITDA	18,273	20,727	15,075	10,472	5,139
EBITDA Margin	26.04%	26.74%	19.64%	10.17%	7.01%
D&A For EBITDA	5,417	5,169	4,986	5,545	5,551
EBIT	12,856	15,558	10,089	4,927	-412.02
EBIT Margin	18.32%	20.07%	13.14%	4.79%	-0.56%
Effective Tax Rate	17.01%	19.76%	18.12%	-	-
Advertising Expenses	70.81	192.85	97.61	84.51	13.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.